Citius Oncology, Inc.
CTORDrug Manufacturers - Specialty & Generic
$0.53−8.20%As of Oct 29vs prior close
- Market cap
- $56M
- P/E (TTM)
- –
- From 52W high
- −69.74%
- EPS (LTM)
- -$0.34
- Dividend yield
- 0.00%
Nomior Score
33
Steady ProfileBottom 19% of the scored universe
Growth59
Quality40
Value56
Momentum26
Resilience25
Connections
Revenue to profitQ3 YE26
The operating loss was 584% of revenue.
Who owns it
1fund